I feel a lot of the press is about er + and breast cancer that is estrogen receptive.
Always about tamoxifen, arimidex etc but nothing about our risks with our dx. I may sound selfish but I wish we had more attention so that we can get more research funds for our treatment.
Hybrid Mode
